Amphastar Pharma AMPH reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Amphastar Pharma beat estimated earnings by 29.17%, reporting an EPS of $0.62 versus an estimate of $0.48.
Revenue was up $19.65 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.32 which was followed by a 14.75% increase in the share price the next day.
Here's a look at Amphastar Pharma's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | 0.41 | 0.39 | 0.36 | 0.36 |
EPS Actual | 0.73 | 0.38 | 0.39 | 0.47 |
Revenue Estimate | 126.98M | 126.37M | 119.30M | 113.33M |
Revenue Actual | 135.02M | 120.13M | 123.47M | 120.37M |
To track all earnings releases for Amphastar Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.